A complementation strategy was developed to define the signaling pathw
ays activated by the Bcr-Abl tyrosine kinase. Transformation inactive
point mutants of Bcr-Abl were tested for complementation with c-Myc. S
ingle point mutations in the Src-homology 2 (SH2) domain, the major ty
rosine autophosphorylation site of the kinase domain, and the Grb-2 bi
nding site in the Bcr region impaired the transformation of fibroblast
s by Bcr-Abl. Hyperexpression of c-Myc efficiently restored transforma
tion activity only to the Bcr-Abl SH2 mutant. These data support a mod
el in which Bcr-Abl activates at least two independent pathways for tr
ansformation. This strategy may be useful for discerning signaling pat
hways activated by other oncogenes.